Legal Representation
Attorney
Holmes W. Anderson
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 3, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Aug 3, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 5, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| May 5, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 5, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 5, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 5, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Dec 31, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 5, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 5, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 16, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 1, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 12, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 12, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 12, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 12, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 14, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 14, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 14, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 8, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 2, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 13, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Software and cloud-based Software As A Service (SaaS) for use with collecting, storing, managing, organizing, and sharing data, images, messages, emails, and medical device data used in the fields of medical and pharmaceutical clinical trials and research, namely, for determining, managing, monitoring, controlling, analyzing, and reporting on the status, performance, safety, and results of medical and pharmaceutical clinical trials and medical research; for the deriving, computing, and determining indicators and metrics of status, performance, safety, results, and outcomes in a medical or pharmaceutical clinical trial or research program; for facilitating decision-making by sponsors of medical and pharmaceutical clinical trials and research regarding the conduct of and adjustments to the execution of a medical and pharmaceutical clinical trial and research to optimize the outcomes; and for communicating, enabling, guiding, facilitating, and tracking the actions taken by medical and pharmaceutical clinical trial and research team personnel
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Educational services, namely, providing classes and training in the fields of the design, planning, implementation and use of software and SAAS services
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Consulting services in the area of the design, planning, implementation, and use of software and SaaS, namely, installation, adaptation, customization, training, and education
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
TRIAL CLARITY
Classification
International Classes
009
041
042
USPTO Documents
Loading USPTO documents...